Slow Capital’s Editas Medicine EDIT Stock Holding History

Slow Capital’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,307	Closed	-$325K	–	161
2018 Q4	$325K	Buy	14,307 +1,718	+14%	+$46.8K	0.16%	131
2018 Q3	$401K	Buy	12,589 +363	+3%	+$11.7K	0.18%	127
2018 Q2	$438K	Sell	12,226 -4,414	-27%	-$156K	0.22%	116
2018 Q1	$552K	Buy	16,640 +296	+2%	+$10.5K	0.25%	112
2017 Q4	$391K	Buy	+16,344	New	+$412K	0.2%	117

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Slow Capital's EDIT Position: Q1 2019 in Review

Slow Capital sold out of Editas Medicine (EDIT) in Q1 2019, closing a stake of 14,307 shares — an estimated $325K sold.

Slow Capital first reported a position in EDIT in Q4 2017 and held it in 5 quarters. The position peaked at $552K in Q1 2018. 201 funds tracked by Wall St. Rank hold EDIT as of Q1 2019.

Slow Capital reported no remaining Editas Medicine position as of Q1 2019 after selling out during the quarter.
Slow Capital sold 14,307 Editas Medicine shares in Q1 2019, an estimated $325K.
Slow Capital first reported a position in Editas Medicine in Q4 2017 and held it in 5 quarters.
Slow Capital's Editas Medicine position peaked at $552K in Q1 2018.
201 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2019.

Based on Slow Capital's 13F filing for Q1 2019, filed 16 May 2019.